Selinexor overcomes hypoxia-induced drug resistance in multiple myeloma

Authors

Barbara Muz, Washington University School of Medicine in St. Louis
Feda Azab, Washington University School of Medicine in St. Louis
Pilar de la Puente, Washington University School of Medicine in St. Louis
Yosef Landesman, Karyopharm Therapeutics
Abdel Kareem Azab, Washington University School of Medicine in St. Louis

Journal

Translational Oncology

Publication Date

2017

Volume

10

Issue

4

Inclusive Pages

632-640

Document Type

Open Access Publication

DOI

10.1016/j.tranon.2017.04.010

Rights and Permissions

Muz B, Azab F, de la Puente P, Landesman Y, Azab AK (2017) Selinexor Overcomes Hypoxia-Induced Drug Resistance in Multiple Myeloma. Translational Oncology, 10(4): 632-640. https://doi.org/10.1016/j.tranon.2017.04.010 © 2017 The Authors. Published by Elsevier Inc. on behalf of Neoplasia Press, Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Recommended Citation

Muz, Barbara; Azab, Feda; de la Puente, Pilar; Landesman, Yosef; and Azab, Abdel Kareem, "Selinexor overcomes hypoxia-induced drug resistance in multiple myeloma." Translational Oncology. 10, 4. 632-640. (2017).
https://digitalcommons.wustl.edu/open_access_pubs/6164